# Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia

> **NCT01929889** · PHASE4 · TERMINATED · sponsor: **Northwestern University** · enrollment: 19 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Iloperidone

## Key facts

- **NCT ID:** NCT01929889
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2014-02
- **Final completion:** 2014-10
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2015-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01929889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01929889, "Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01929889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
